首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report (vol 70, pg 859, 2017)

【24h】

Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report (vol 70, pg 859, 2017)

机译：口腔抗凝血剂，以防止CKD第5D阶段患者非血清心房颤动的卒中：NKF-KDOQI争议报告（第70卷，PG 859,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Journal of Kidney Diseases: The official journal of the National Kidney Foundation》 |2019年第4期|共3页
作者
Bansal Vinod K.; Herzog Charles A.; Sarnak Mark J.; Choi Michael J.; Mehta Ravindra; Jaar Bernard; Rocco Michael V.; Kramer Holly;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
专利

1. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report (vol 70, pg 859, 2017) [J] . Bansal Vinod K., Herzog Charles A., Sarnak Mark J., American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2019,第4期

机译：口腔抗凝血剂，以防止CKD第5D阶段患者非血清心房颤动的卒中：NKF-KDOQI争议报告（第70卷，PG 859,2017）
2. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report [J] . Vinod K. Bansal, Charles A. Herzog, Mark J. Sarnak, American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2017,第6期

机译：口腔抗凝血剂，以防止CKD阶段5D患者非衰弱性心房颤动：NKF-KDOQI争议报告
3. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report [J] . Vinod K. Bansal, Charles A. Herzog, Mark J. Sarnak, Cotton; Review of the World Situation . 2017,第6期

机译：口腔抗凝血剂，以防止CKD阶段5D患者非衰弱性心房颤动：NKF-KDOQI争议报告
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Dabigatran versus warfarin for the prevention of stroke in patients with chronic nonvalvular atrial fibrillation. [D] . Qiu, Fen. 2011

机译：达比加群与华法林预防慢性非瓣膜性房颤患者的中风。
6. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation [O] . Jerome Ment 2015

机译：直接口服抗凝剂：预防非瓣膜性房颤患者中风的关键考虑因素
7. Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks [O] . Maria I. Aguilar, Robert Hart 2008

机译：口腔抗凝血剂与抗血小板治疗预防患者患者患者，患者患者患者，没有中风或短暂性缺血性发作

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号